A CASE OF HYPOGONADOTROPIC HYPOGONADISM: A VARIANT WITH HIGHER RISK OF OHSS.

Dr Garima Sachdeva, Dr Shalini Gainder

Abstract


OHSS, though a rare complication of ovarian stimulation, but if not detected early and adequately managed can lead to life threatening
consequences.
Objective: To report a case of a variant of hypogonadotropic hypogonadism with severe OHSS and to discuss the risk factors and strategies of
prevention.
Case report: Here, we present a case of hypogonadotropic hypogonadism with polycystic ovarian morphology. She was a thin built woman with
eight years of infertility. Her AMH value was on a higher side and on ovulation induction. She developed severe late onset OHSS on day 11 of the
HCG trigger which was successfully managed.
Conclusion: While doing ovulation induction in patients with hypogonadotropic hypogonadism, it should be kept in mind that there exists a
variant with polycystic ovarian morphology (PCOM), who might show hyper-response to gonadotropin stimulation. These are the patients who are
at high risk of OHSS and need more frequent monitoring. Serum AMH and polycystic morphology on stimulation can help suspect OHSS at an
early stage. Luteal coasting or use of progesterone’s in place of HCG for luteal phase support can help in decreasing the risk of severe OHSS.


Keywords


OHSS, PCOS, Hypogonadism, AMH, HCG

Full Text:

PDF

References


Kumar P, Sait SF, Sharma A, Kumar M. Ovarian hyperstimulation syndrome. J Hum Reprod Sci. 2011;4(2):70-5.

Katsikis I, Kita M, Karkanaki A, Prapas N, Panidis D. Anovulation and ovulation induction. Hippokratia. 2006;10(3):120-7.

Shoham Z, Conway GS, Patel A, Jacobs HS. Polycystic ovaries in patients with hypogonadotropic hypogonadism: similarity of ovarian response to gonadotropin stimulation in patients with polycystic ovarian syndrome. Fertil Steril. 1992;58(1):37-45.

Pandurangi M, Tamizharasi M, Reddy NS. Pregnancy outcome of assisted reproductive technology cycle in patients with hypogonadotropic hypogonadism. J Hum Reprod Sci. 2015;8(3):146-50.

Lee TH, Liu CH, Huang CC, Wu YL, Shih YT, Ho HN, et al. Serum anti-Mullerian hormone and estradiol levels as predictors of ovarian hyperstimulation syndrome in assisted reproduction technology cycles. Hum Reprod. 2008;23(1):160-7.

Practice Committee of the American Society for Reproductive Medicine. Electronic address Aao, Practice Committee of the American Society for Reproductive M. Prevention and treatment of moderate and severe ovarian hyperstimulation syndrome: a guideline. Fertil Steril. 2016;106(7):1634-47.

Nastri CO, Ferriani RA, Rocha IA, Martins WP. Ovarian hyperstimulation syndrome: pathophysiology and prevention. J Assist Reprod Genet. 2010;27(2-3):121-8.

Namavar Jahromi BM, Parsanezhad MM, Shomali ZM, Bakhshai PM, Alborzi MM, Moin Vaziri NMDP, et al. Ovarian Hyperstimulation Syndrome: A Narrative Review of Its Pathophysiology, Risk Factors, Prevention, Classification, and Management. Iran J Med Sci. 2018;43(3):248-60.

Kol S, Solt I. GnRH agonist for triggering final oocyte maturation in patients at risk of ovarian hyperstimulation syndrome: still a controversy? J Assist Reprod Genet. 2008;25(2-3):63-6.

Lee KH, Kim SH, Jee BC, Kim YJ, Suh CS, Kim KC, et al. Comparison of clinical characteristics between early and late patterns in hospitalized patients with ovarian hyperstimulation syndrome. Fertil Steril. 2010;93(7):2274-80.

Griesinger G, Verweij PJ, Gates D, Devroey P, Gordon K, Stegmann BJ, et al. Prediction of Ovarian Hyperstimulation Syndrome in Patients Treated with Corifollitropin alfa or rFSH in a GnRH Antagonist Protocol. PLoS One. 2016;11(3):e0149615.

Mahajan N, Gupta S, Sharma S, Rani K, Naidu P, Arora PR. Early onset ovarian hyperstimulation syndrome despite use of segmentation approach and ovarian hyperstimulation syndrome prophylaxis. J Hum Reprod Sci. 2015;8(4):234-8.

Varnagy A, Bodis J, Manfai Z, Wilhelm F, Busznyak C, Koppan M. Low-dose aspirin therapy to prevent ovarian hyperstimulation syndrome. Fertil Steril. 2010;93(7):2281-4.

Palomba S, Falbo A, Carrillo L, Villani MT, Orio F, Russo T, et al. Metformin reduces risk of ovarian hyperstimulation syndrome in patients with polycystic ovary syndrome during gonadotropin-stimulated in vitro fertilization cycles: a randomized, controlled trial. Fertil Steril. 2011;96(6):1384-90 e4.

Haas J, Yinon Y, Meridor K, Orvieto R. Pregnancy outcome in severe OHSS patients following ascitic/plerural fluid drainage. J Ovarian Res. 2014;7:56.


Refbacks

  • There are currently no refbacks.